id: NEW:resveratrol_intake_to_NEW:hepatic_fibrosis
name: Resveratrol Intake â†’ Hepatic Fibrosis
from_node:
  node_id: NEW:resveratrol_intake
  node_name: Resveratrol Intake
to_node:
  node_id: NEW:hepatic_fibrosis
  node_name: Hepatic Fibrosis
direction: negative
category: biological
mechanism_pathway:
- 'Step 1: Resveratrol is absorbed and reaches hepatic tissue where it exerts antioxidative
  properties'
- 'Step 2: Resveratrol reduces oxidative stress and inflammatory responses in hepatocytes
  through multiple pathways'
- 'Step 3: Decreased oxidative damage reduces hepatic stellate cell activation, which
  is the primary driver of fibrogenesis'
- 'Step 4: Resveratrol modulates insulin resistance and improves lipid metabolism,
  reducing hepatic steatosis that precedes fibrosis'
- 'Step 5: Combined anti-inflammatory, antioxidant, and metabolic effects lead to
  reduced collagen deposition and hepatic fibrosis'
evidence:
  quality_rating: A
  n_studies: 76
  primary_citation: 'Forouzan Faghihzadeh et al. 2015. Resveratrol and liver: A systematic
    review. Journal of Research in Medical Sciences.'
  supporting_citations: []
description: This systematic review of 76 preclinical studies demonstrates that resveratrol
  reduces hepatic fibrosis through its antioxidative properties across different models
  of hepatitis and liver injury. The compound provides hepatoprotection against chemical,
  cholestatic, and alcohol-induced injury while improving glucose metabolism and lipid
  profiles. These metabolic improvements, combined with direct antioxidant effects,
  lead to reduced hepatic stellate cell activation and diminished fibrogenesis.
last_updated: '2025-12-02'
extraction_method: consolidated_batch_v3
moderators:
- name: hepatic steatosis presence
  direction: strengthens
  strength: moderate
  description: Resveratrol effects on fibrosis appear more pronounced in models with
    underlying hepatic steatosis
- name: type of liver injury
  direction: strengthens
  strength: moderate
  description: Efficacy demonstrated across chemical, cholestatic, alcohol-induced,
    and ischemic liver injury models
